Joint damage in young adults with juvenile arthritis after transition to adult care
Treatments studied
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study looks at joint damage in young people with juvenile idiopathic arthritis (JIA) who have moved from pediatric to adult rheumatology care. It aims to understand how their joints are affected after this transition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 16 and 25 years old.
- You were diagnosed with juvenile idiopathic arthritis (JIA) as a child.
- You have started the process of moving from a pediatric to an adult rheumatology clinic.
- You have had X-rays of your hands, hips, and knees taken that show your growth plates are closed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether children with early juvenile idiopathic arthritis do better by starting with one treatment approach and adjusting (stepping up or stepping down) based on how their arthritis responds. It may help find the safest, most effective long-term plan for controlling symptoms with fewer side effects.
This study looks at whether it is safe to stop or reduce arthritis medication in children with juvenile idiopathic arthritis (JIA) whose disease has been inactive for at least 6 months. The goal is to find a personalized approach to help each child when their medication is no longer needed.
This study looks at how to improve the shift from pediatric to adult rheumatology care for young people with chronic inflammatory rheumatic diseases. It aims to understand how healthcare services can better support this transition.
This study follows children and young adults newly diagnosed with certain types of arthritis or related conditions to learn more about their health over time. It may help doctors better understand how these diseases progress and how treatments work.
This trial tests whether children with juvenile idiopathic arthritis (JIA) who have been doing well for over a year can safely reduce their medications. The goal is to find the best way to keep arthritis under control while avoiding unnecessary treatments.
This study follows people with systemic juvenile idiopathic arthritis (sJIA), adult-onset Still’s disease (AOSD), and similar conditions to learn how the illness works over time. It also collects blood and family information to study genetics and explain what causes flare-ups, which may help future care.
Hear when a new Juvenile Chronic Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.